nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—ABCB1—kidney cancer	0.13	1	CbGaD
Methadone—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0436	0.0666	CbGbCtD
Methadone—CYP3A7—Temsirolimus—kidney cancer	0.0436	0.0666	CbGbCtD
Methadone—CYP19A1—Paclitaxel—kidney cancer	0.0346	0.0527	CbGbCtD
Methadone—CYP3A5—Temsirolimus—kidney cancer	0.0327	0.0499	CbGbCtD
Methadone—ABCB1—Temsirolimus—kidney cancer	0.0213	0.0325	CbGbCtD
Methadone—CYP2D6—Temsirolimus—kidney cancer	0.0201	0.0306	CbGbCtD
Methadone—CYP3A4—Everolimus—kidney cancer	0.0189	0.0288	CbGbCtD
Methadone—CYP2C8—Pazopanib—kidney cancer	0.0165	0.0252	CbGbCtD
Methadone—CYP3A7—Paclitaxel—kidney cancer	0.015	0.0228	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.015	0.0228	CbGbCtD
Methadone—CYP3A7—Sorafenib—kidney cancer	0.0133	0.0203	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0133	0.0203	CbGbCtD
Methadone—CYP3A7—Vincristine—kidney cancer	0.0129	0.0197	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0129	0.0197	CbGbCtD
Methadone—CYP1A2—Pazopanib—kidney cancer	0.0128	0.0195	CbGbCtD
Methadone—CYP3A4—Temsirolimus—kidney cancer	0.0128	0.0195	CbGbCtD
Methadone—CYP2B6—Sorafenib—kidney cancer	0.0127	0.0193	CbGbCtD
Methadone—CYP3A5—Erlotinib—kidney cancer	0.0123	0.0187	CbGbCtD
Methadone—CYP2C9—Capecitabine—kidney cancer	0.012	0.0183	CbGbCtD
Methadone—CYP2C8—Erlotinib—kidney cancer	0.0118	0.018	CbGbCtD
Methadone—CYP3A5—Paclitaxel—kidney cancer	0.0112	0.0171	CbGbCtD
Methadone—ABCB1—Pazopanib—kidney cancer	0.0112	0.0171	CbGbCtD
Methadone—CYP2C8—Paclitaxel—kidney cancer	0.0108	0.0165	CbGbCtD
Methadone—CYP3A7—Sunitinib—kidney cancer	0.0108	0.0164	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0108	0.0164	CbGbCtD
Methadone—CYP2D6—Pazopanib—kidney cancer	0.0105	0.0161	CbGbCtD
Methadone—ABCB1—Dactinomycin—kidney cancer	0.0102	0.0156	CbGbCtD
Methadone—CYP3A5—Sorafenib—kidney cancer	0.00997	0.0152	CbGbCtD
Methadone—CYP3A5—Vincristine—kidney cancer	0.00968	0.0148	CbGbCtD
Methadone—CYP2C8—Sorafenib—kidney cancer	0.00959	0.0146	CbGbCtD
Methadone—CYP1A2—Erlotinib—kidney cancer	0.00913	0.0139	CbGbCtD
Methadone—ABCB1—Gemcitabine—kidney cancer	0.00809	0.0123	CbGbCtD
Methadone—CYP3A5—Sunitinib—kidney cancer	0.00808	0.0123	CbGbCtD
Methadone—CYP2C19—Sorafenib—kidney cancer	0.00804	0.0123	CbGbCtD
Methadone—ABCB1—Erlotinib—kidney cancer	0.00798	0.0122	CbGbCtD
Methadone—CYP2B6—Doxorubicin—kidney cancer	0.00768	0.0117	CbGbCtD
Methadone—CYP2C9—Paclitaxel—kidney cancer	0.00753	0.0115	CbGbCtD
Methadone—CYP2D6—Erlotinib—kidney cancer	0.00752	0.0115	CbGbCtD
Methadone—CYP1A2—Sorafenib—kidney cancer	0.00742	0.0113	CbGbCtD
Methadone—ABCB1—Paclitaxel—kidney cancer	0.00731	0.0112	CbGbCtD
Methadone—CYP3A4—Pazopanib—kidney cancer	0.0067	0.0102	CbGbCtD
Methadone—CYP2C9—Sorafenib—kidney cancer	0.00669	0.0102	CbGbCtD
Methadone—ABCB1—Sorafenib—kidney cancer	0.00649	0.0099	CbGbCtD
Methadone—ABCB1—Vinblastine—kidney cancer	0.00641	0.00978	CbGbCtD
Methadone—ABCB1—Vincristine—kidney cancer	0.0063	0.00961	CbGbCtD
Methadone—CYP2D6—Sorafenib—kidney cancer	0.00611	0.00933	CbGbCtD
Methadone—CYP2D6—Vinblastine—kidney cancer	0.00604	0.00922	CbGbCtD
Methadone—ABCB1—Sunitinib—kidney cancer	0.00526	0.00802	CbGbCtD
Methadone—CYP3A4—Erlotinib—kidney cancer	0.00478	0.0073	CbGbCtD
Methadone—CYP3A4—Paclitaxel—kidney cancer	0.00438	0.00668	CbGbCtD
Methadone—ABCB1—Doxorubicin—kidney cancer	0.00394	0.00601	CbGbCtD
Methadone—CYP3A4—Sorafenib—kidney cancer	0.00389	0.00593	CbGbCtD
Methadone—CYP3A4—Vinblastine—kidney cancer	0.00384	0.00586	CbGbCtD
Methadone—CYP3A4—Vincristine—kidney cancer	0.00377	0.00576	CbGbCtD
Methadone—CYP2D6—Doxorubicin—kidney cancer	0.00371	0.00566	CbGbCtD
Methadone—CYP3A4—Sunitinib—kidney cancer	0.00315	0.00481	CbGbCtD
Methadone—CYP3A4—Doxorubicin—kidney cancer	0.00236	0.0036	CbGbCtD
Methadone—CYP2C19—urine—kidney cancer	0.00172	0.108	CbGeAlD
Methadone—CYP1A2—urine—kidney cancer	0.0014	0.0885	CbGeAlD
Methadone—CYP2C9—urine—kidney cancer	0.00133	0.084	CbGeAlD
Methadone—CYP3A4—urine—kidney cancer	0.00102	0.0641	CbGeAlD
Methadone—CYP2D6—urine—kidney cancer	0.001	0.063	CbGeAlD
Methadone—OPRD1—renal system—kidney cancer	0.000895	0.0564	CbGeAlD
Methadone—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00088	0.0555	CbGeAlD
Methadone—OPRD1—kidney—kidney cancer	0.000865	0.0545	CbGeAlD
Methadone—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000754	0.0475	CbGeAlD
Methadone—Loperamide—POMC—kidney cancer	0.00064	0.255	CrCbGaD
Methadone—CYP19A1—gonad—kidney cancer	0.00046	0.029	CbGeAlD
Methadone—CYP2C8—renal system—kidney cancer	0.000367	0.0231	CbGeAlD
Methadone—CYP3A5—nephron tubule—kidney cancer	0.000364	0.023	CbGeAlD
Methadone—CYP2B6—nephron tubule—kidney cancer	0.000362	0.0228	CbGeAlD
Methadone—CYP2C8—kidney—kidney cancer	0.000355	0.0224	CbGeAlD
Methadone—CYP1A2—renal system—kidney cancer	0.000343	0.0217	CbGeAlD
Methadone—CYP3A5—renal system—kidney cancer	0.000331	0.0209	CbGeAlD
Methadone—CYP2B6—renal system—kidney cancer	0.000329	0.0208	CbGeAlD
Methadone—Oxaprozin—PTGS1—kidney cancer	0.000322	0.128	CrCbGaD
Methadone—CYP3A5—kidney—kidney cancer	0.00032	0.0202	CbGeAlD
Methadone—CYP2B6—kidney—kidney cancer	0.000318	0.0201	CbGeAlD
Methadone—CYP3A5—cortex of kidney—kidney cancer	0.000312	0.0197	CbGeAlD
Methadone—CYP2B6—gonad—kidney cancer	0.000295	0.0186	CbGeAlD
Methadone—Ethopropazine—BCHE—kidney cancer	0.000276	0.11	CrCbGaD
Methadone—CYP3A4—renal system—kidney cancer	0.000249	0.0157	CbGeAlD
Methadone—CYP2D6—renal system—kidney cancer	0.000245	0.0154	CbGeAlD
Methadone—CYP3A4—kidney—kidney cancer	0.00024	0.0152	CbGeAlD
Methadone—CYP2D6—kidney—kidney cancer	0.000237	0.0149	CbGeAlD
Methadone—Phenylbutazone—PTGS1—kidney cancer	0.000213	0.0847	CrCbGaD
Methadone—ABCB1—nephron tubule—kidney cancer	0.000194	0.0122	CbGeAlD
Methadone—Weight increased—Capecitabine—kidney cancer	0.000191	0.00128	CcSEcCtD
Methadone—Hypersensitivity—Everolimus—kidney cancer	0.000191	0.00128	CcSEcCtD
Methadone—Flushing—Paclitaxel—kidney cancer	0.00019	0.00127	CcSEcCtD
Methadone—Weight decreased—Capecitabine—kidney cancer	0.00019	0.00127	CcSEcCtD
Methadone—Decreased appetite—Sunitinib—kidney cancer	0.000188	0.00126	CcSEcCtD
Methadone—Asthenia—Vinblastine—kidney cancer	0.000186	0.00125	CcSEcCtD
Methadone—Asthenia—Everolimus—kidney cancer	0.000186	0.00124	CcSEcCtD
Methadone—Constipation—Sunitinib—kidney cancer	0.000185	0.00124	CcSEcCtD
Methadone—Pain—Sunitinib—kidney cancer	0.000185	0.00124	CcSEcCtD
Methadone—Oxaprozin—PTGS2—kidney cancer	0.000184	0.0733	CrCbGaD
Methadone—Gastrointestinal pain—Sorafenib—kidney cancer	0.000184	0.00123	CcSEcCtD
Methadone—Chills—Paclitaxel—kidney cancer	0.000183	0.00123	CcSEcCtD
Methadone—Pruritus—Everolimus—kidney cancer	0.000183	0.00123	CcSEcCtD
Methadone—Anaphylactic shock—Vincristine—kidney cancer	0.000183	0.00122	CcSEcCtD
Methadone—Oedema—Vincristine—kidney cancer	0.000183	0.00122	CcSEcCtD
Methadone—Arrhythmia—Paclitaxel—kidney cancer	0.000183	0.00122	CcSEcCtD
Methadone—Phlebitis—Doxorubicin—kidney cancer	0.000181	0.00121	CcSEcCtD
Methadone—Asthenia—Erlotinib—kidney cancer	0.000179	0.0012	CcSEcCtD
Methadone—Thrombocytopenia—Vincristine—kidney cancer	0.000179	0.0012	CcSEcCtD
Methadone—Urticaria—Sorafenib—kidney cancer	0.000178	0.0012	CcSEcCtD
Methadone—Erythema—Paclitaxel—kidney cancer	0.000178	0.00119	CcSEcCtD
Methadone—Decreased appetite—Dactinomycin—kidney cancer	0.000178	0.00119	CcSEcCtD
Methadone—Diarrhoea—Vinblastine—kidney cancer	0.000178	0.00119	CcSEcCtD
Methadone—Abdominal pain—Sorafenib—kidney cancer	0.000178	0.00119	CcSEcCtD
Methadone—Body temperature increased—Sorafenib—kidney cancer	0.000178	0.00119	CcSEcCtD
Methadone—Diarrhoea—Everolimus—kidney cancer	0.000177	0.00119	CcSEcCtD
Methadone—Gastrointestinal pain—Sunitinib—kidney cancer	0.000177	0.00118	CcSEcCtD
Methadone—Hyperhidrosis—Vincristine—kidney cancer	0.000177	0.00118	CcSEcCtD
Methadone—Pruritus—Erlotinib—kidney cancer	0.000177	0.00118	CcSEcCtD
Methadone—ABCB1—renal system—kidney cancer	0.000176	0.0111	CbGeAlD
Methadone—Pain—Dactinomycin—kidney cancer	0.000175	0.00117	CcSEcCtD
Methadone—Anorexia—Vincristine—kidney cancer	0.000174	0.00117	CcSEcCtD
Methadone—Oedema—Gemcitabine—kidney cancer	0.000173	0.00116	CcSEcCtD
Methadone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000173	0.00116	CcSEcCtD
Methadone—Dizziness—Vinblastine—kidney cancer	0.000172	0.00115	CcSEcCtD
Methadone—Dizziness—Everolimus—kidney cancer	0.000171	0.00115	CcSEcCtD
Methadone—Muscle spasms—Paclitaxel—kidney cancer	0.000171	0.00115	CcSEcCtD
Methadone—Abdominal pain—Sunitinib—kidney cancer	0.000171	0.00114	CcSEcCtD
Methadone—Body temperature increased—Sunitinib—kidney cancer	0.000171	0.00114	CcSEcCtD
Methadone—Diarrhoea—Erlotinib—kidney cancer	0.000171	0.00114	CcSEcCtD
Methadone—Hypotension—Vincristine—kidney cancer	0.000171	0.00114	CcSEcCtD
Methadone—Bradycardia—Capecitabine—kidney cancer	0.000171	0.00114	CcSEcCtD
Methadone—ABCB1—kidney—kidney cancer	0.00017	0.0107	CbGeAlD
Methadone—Thrombocytopenia—Gemcitabine—kidney cancer	0.00017	0.00114	CcSEcCtD
Methadone—Feeling abnormal—Dactinomycin—kidney cancer	0.000169	0.00113	CcSEcCtD
Methadone—Hyperhidrosis—Gemcitabine—kidney cancer	0.000168	0.00112	CcSEcCtD
Methadone—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000167	0.00112	CcSEcCtD
Methadone—Tremor—Paclitaxel—kidney cancer	0.000167	0.00112	CcSEcCtD
Methadone—ABCB1—cortex of kidney—kidney cancer	0.000166	0.0104	CbGeAlD
Methadone—Hypersensitivity—Sorafenib—kidney cancer	0.000166	0.00111	CcSEcCtD
Methadone—Insomnia—Vincristine—kidney cancer	0.000165	0.00111	CcSEcCtD
Methadone—Anorexia—Gemcitabine—kidney cancer	0.000165	0.00111	CcSEcCtD
Methadone—Vomiting—Vinblastine—kidney cancer	0.000165	0.00111	CcSEcCtD
Methadone—Dizziness—Erlotinib—kidney cancer	0.000165	0.00111	CcSEcCtD
Methadone—Vomiting—Everolimus—kidney cancer	0.000165	0.0011	CcSEcCtD
Methadone—Agitation—Paclitaxel—kidney cancer	0.000164	0.0011	CcSEcCtD
Methadone—Rash—Everolimus—kidney cancer	0.000163	0.00109	CcSEcCtD
Methadone—Dermatitis—Everolimus—kidney cancer	0.000163	0.00109	CcSEcCtD
Methadone—Headache—Vinblastine—kidney cancer	0.000163	0.00109	CcSEcCtD
Methadone—Headache—Everolimus—kidney cancer	0.000162	0.00109	CcSEcCtD
Methadone—Hypotension—Gemcitabine—kidney cancer	0.000162	0.00109	CcSEcCtD
Methadone—Body temperature increased—Dactinomycin—kidney cancer	0.000162	0.00108	CcSEcCtD
Methadone—Abdominal pain—Dactinomycin—kidney cancer	0.000162	0.00108	CcSEcCtD
Methadone—Visual impairment—Capecitabine—kidney cancer	0.000162	0.00108	CcSEcCtD
Methadone—Asthenia—Sorafenib—kidney cancer	0.000161	0.00108	CcSEcCtD
Methadone—Cardiac failure—Doxorubicin—kidney cancer	0.00016	0.00107	CcSEcCtD
Methadone—Vertigo—Paclitaxel—kidney cancer	0.00016	0.00107	CcSEcCtD
Methadone—Syncope—Paclitaxel—kidney cancer	0.00016	0.00107	CcSEcCtD
Methadone—Hypersensitivity—Sunitinib—kidney cancer	0.000159	0.00107	CcSEcCtD
Methadone—Decreased appetite—Vincristine—kidney cancer	0.000159	0.00106	CcSEcCtD
Methadone—Pruritus—Sorafenib—kidney cancer	0.000159	0.00106	CcSEcCtD
Methadone—Vomiting—Erlotinib—kidney cancer	0.000159	0.00106	CcSEcCtD
Methadone—ABCB1—gonad—kidney cancer	0.000158	0.00995	CbGeAlD
Methadone—Rash—Erlotinib—kidney cancer	0.000157	0.00105	CcSEcCtD
Methadone—Dermatitis—Erlotinib—kidney cancer	0.000157	0.00105	CcSEcCtD
Methadone—Palpitations—Paclitaxel—kidney cancer	0.000157	0.00105	CcSEcCtD
Methadone—Insomnia—Gemcitabine—kidney cancer	0.000157	0.00105	CcSEcCtD
Methadone—Headache—Erlotinib—kidney cancer	0.000156	0.00105	CcSEcCtD
Methadone—Loss of consciousness—Paclitaxel—kidney cancer	0.000156	0.00105	CcSEcCtD
Methadone—Constipation—Vincristine—kidney cancer	0.000156	0.00105	CcSEcCtD
Methadone—Pain—Vincristine—kidney cancer	0.000156	0.00105	CcSEcCtD
Methadone—Flushing—Capecitabine—kidney cancer	0.000156	0.00104	CcSEcCtD
Methadone—Asthenia—Sunitinib—kidney cancer	0.000155	0.00104	CcSEcCtD
Methadone—Nausea—Vinblastine—kidney cancer	0.000154	0.00103	CcSEcCtD
Methadone—Somnolence—Gemcitabine—kidney cancer	0.000154	0.00103	CcSEcCtD
Methadone—Convulsion—Paclitaxel—kidney cancer	0.000154	0.00103	CcSEcCtD
Methadone—Nausea—Everolimus—kidney cancer	0.000154	0.00103	CcSEcCtD
Methadone—Diarrhoea—Sorafenib—kidney cancer	0.000154	0.00103	CcSEcCtD
Methadone—Pruritus—Sunitinib—kidney cancer	0.000153	0.00102	CcSEcCtD
Methadone—Anxiety—Paclitaxel—kidney cancer	0.000151	0.00101	CcSEcCtD
Methadone—Decreased appetite—Gemcitabine—kidney cancer	0.000151	0.00101	CcSEcCtD
Methadone—Hypersensitivity—Dactinomycin—kidney cancer	0.000151	0.00101	CcSEcCtD
Methadone—Chills—Capecitabine—kidney cancer	0.000151	0.00101	CcSEcCtD
Methadone—Arrhythmia—Capecitabine—kidney cancer	0.00015	0.001	CcSEcCtD
Methadone—Gastrointestinal pain—Vincristine—kidney cancer	0.00015	0.001	CcSEcCtD
Methadone—Cardiac arrest—Doxorubicin—kidney cancer	0.000149	0.000995	CcSEcCtD
Methadone—Dizziness—Sorafenib—kidney cancer	0.000149	0.000995	CcSEcCtD
Methadone—Pain—Gemcitabine—kidney cancer	0.000148	0.000993	CcSEcCtD
Methadone—Constipation—Gemcitabine—kidney cancer	0.000148	0.000993	CcSEcCtD
Methadone—Nausea—Erlotinib—kidney cancer	0.000148	0.000993	CcSEcCtD
Methadone—Dry mouth—Paclitaxel—kidney cancer	0.000148	0.000992	CcSEcCtD
Methadone—Diarrhoea—Sunitinib—kidney cancer	0.000148	0.00099	CcSEcCtD
Methadone—Asthenia—Dactinomycin—kidney cancer	0.000147	0.000983	CcSEcCtD
Methadone—Confusional state—Paclitaxel—kidney cancer	0.000146	0.000981	CcSEcCtD
Methadone—Erythema—Capecitabine—kidney cancer	0.000146	0.000978	CcSEcCtD
Methadone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000145	0.000972	CcSEcCtD
Methadone—Oedema—Paclitaxel—kidney cancer	0.000145	0.000972	CcSEcCtD
Methadone—Abdominal pain—Vincristine—kidney cancer	0.000145	0.000968	CcSEcCtD
Methadone—Body temperature increased—Vincristine—kidney cancer	0.000145	0.000968	CcSEcCtD
Methadone—Dizziness—Sunitinib—kidney cancer	0.000143	0.000957	CcSEcCtD
Methadone—Feeling abnormal—Gemcitabine—kidney cancer	0.000143	0.000957	CcSEcCtD
Methadone—Shock—Paclitaxel—kidney cancer	0.000143	0.000957	CcSEcCtD
Methadone—Vomiting—Sorafenib—kidney cancer	0.000143	0.000956	CcSEcCtD
Methadone—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000143	0.000956	CcSEcCtD
Methadone—Hypokalaemia—Doxorubicin—kidney cancer	0.000142	0.000953	CcSEcCtD
Methadone—Thrombocytopenia—Paclitaxel—kidney cancer	0.000142	0.000952	CcSEcCtD
Methadone—Tachycardia—Paclitaxel—kidney cancer	0.000142	0.000949	CcSEcCtD
Methadone—Rash—Sorafenib—kidney cancer	0.000142	0.000949	CcSEcCtD
Methadone—Dermatitis—Sorafenib—kidney cancer	0.000142	0.000948	CcSEcCtD
Methadone—Headache—Sorafenib—kidney cancer	0.000141	0.000942	CcSEcCtD
Methadone—Muscle spasms—Capecitabine—kidney cancer	0.00014	0.00094	CcSEcCtD
Methadone—Hyperhidrosis—Paclitaxel—kidney cancer	0.00014	0.00094	CcSEcCtD
Methadone—Diarrhoea—Dactinomycin—kidney cancer	0.00014	0.000938	CcSEcCtD
Methadone—Nasopharyngitis—Doxorubicin—kidney cancer	0.00014	0.000936	CcSEcCtD
Methadone—Anorexia—Paclitaxel—kidney cancer	0.000138	0.000927	CcSEcCtD
Methadone—Vomiting—Sunitinib—kidney cancer	0.000137	0.00092	CcSEcCtD
Methadone—Body temperature increased—Gemcitabine—kidney cancer	0.000137	0.000918	CcSEcCtD
Methadone—Tremor—Capecitabine—kidney cancer	0.000137	0.000916	CcSEcCtD
Methadone—Rash—Sunitinib—kidney cancer	0.000136	0.000913	CcSEcCtD
Methadone—Dermatitis—Sunitinib—kidney cancer	0.000136	0.000912	CcSEcCtD
Methadone—Hypotension—Paclitaxel—kidney cancer	0.000136	0.000909	CcSEcCtD
Methadone—Headache—Sunitinib—kidney cancer	0.000135	0.000907	CcSEcCtD
Methadone—Hypersensitivity—Vincristine—kidney cancer	0.000135	0.000902	CcSEcCtD
Methadone—Nausea—Sorafenib—kidney cancer	0.000133	0.000894	CcSEcCtD
Methadone—Insomnia—Paclitaxel—kidney cancer	0.000131	0.00088	CcSEcCtD
Methadone—Vertigo—Capecitabine—kidney cancer	0.000131	0.000879	CcSEcCtD
Methadone—Asthenia—Vincristine—kidney cancer	0.000131	0.000878	CcSEcCtD
Methadone—Syncope—Capecitabine—kidney cancer	0.000131	0.000877	CcSEcCtD
Methadone—Vomiting—Dactinomycin—kidney cancer	0.00013	0.000871	CcSEcCtD
Methadone—Somnolence—Paclitaxel—kidney cancer	0.000129	0.000865	CcSEcCtD
Methadone—Palpitations—Capecitabine—kidney cancer	0.000129	0.000864	CcSEcCtD
Methadone—Rash—Dactinomycin—kidney cancer	0.000129	0.000864	CcSEcCtD
Methadone—Nausea—Sunitinib—kidney cancer	0.000128	0.00086	CcSEcCtD
Methadone—Loss of consciousness—Capecitabine—kidney cancer	0.000128	0.000859	CcSEcCtD
Methadone—Decreased appetite—Paclitaxel—kidney cancer	0.000126	0.000845	CcSEcCtD
Methadone—Diarrhoea—Vincristine—kidney cancer	0.000125	0.000838	CcSEcCtD
Methadone—Asthenia—Gemcitabine—kidney cancer	0.000124	0.000833	CcSEcCtD
Methadone—Pain—Paclitaxel—kidney cancer	0.000124	0.000832	CcSEcCtD
Methadone—Constipation—Paclitaxel—kidney cancer	0.000124	0.000832	CcSEcCtD
Methadone—Anxiety—Capecitabine—kidney cancer	0.000124	0.00083	CcSEcCtD
Methadone—Weight increased—Doxorubicin—kidney cancer	0.000123	0.000823	CcSEcCtD
Methadone—Pruritus—Gemcitabine—kidney cancer	0.000123	0.000822	CcSEcCtD
Methadone—Weight decreased—Doxorubicin—kidney cancer	0.000122	0.000818	CcSEcCtD
Methadone—Dry mouth—Capecitabine—kidney cancer	0.000122	0.000814	CcSEcCtD
Methadone—Nausea—Dactinomycin—kidney cancer	0.000122	0.000814	CcSEcCtD
Methadone—Phenylbutazone—PTGS2—kidney cancer	0.000122	0.0484	CrCbGaD
Methadone—Dizziness—Vincristine—kidney cancer	0.000121	0.00081	CcSEcCtD
Methadone—Drowsiness—Doxorubicin—kidney cancer	0.00012	0.000807	CcSEcCtD
Methadone—Confusional state—Capecitabine—kidney cancer	0.00012	0.000805	CcSEcCtD
Methadone—Fexofenadine—ABCB1—kidney cancer	0.00012	0.0478	CrCbGaD
Methadone—Feeling abnormal—Paclitaxel—kidney cancer	0.00012	0.000801	CcSEcCtD
Methadone—Oedema—Capecitabine—kidney cancer	0.000119	0.000798	CcSEcCtD
Methadone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000119	0.000795	CcSEcCtD
Methadone—Diarrhoea—Gemcitabine—kidney cancer	0.000119	0.000795	CcSEcCtD
Methadone—Shock—Capecitabine—kidney cancer	0.000117	0.000785	CcSEcCtD
Methadone—Thrombocytopenia—Capecitabine—kidney cancer	0.000117	0.000781	CcSEcCtD
Methadone—Tachycardia—Capecitabine—kidney cancer	0.000116	0.000779	CcSEcCtD
Methadone—Vomiting—Vincristine—kidney cancer	0.000116	0.000778	CcSEcCtD
Methadone—Diphenhydramine—PTGS1—kidney cancer	0.000116	0.0461	CrCbGaD
Methadone—Sweating—Doxorubicin—kidney cancer	0.000115	0.000773	CcSEcCtD
Methadone—Urticaria—Paclitaxel—kidney cancer	0.000115	0.000773	CcSEcCtD
Methadone—Rash—Vincristine—kidney cancer	0.000115	0.000772	CcSEcCtD
Methadone—Hyperhidrosis—Capecitabine—kidney cancer	0.000115	0.000771	CcSEcCtD
Methadone—Dermatitis—Vincristine—kidney cancer	0.000115	0.000771	CcSEcCtD
Methadone—Body temperature increased—Paclitaxel—kidney cancer	0.000115	0.000769	CcSEcCtD
Methadone—Abdominal pain—Paclitaxel—kidney cancer	0.000115	0.000769	CcSEcCtD
Methadone—Headache—Vincristine—kidney cancer	0.000115	0.000767	CcSEcCtD
Methadone—Anorexia—Capecitabine—kidney cancer	0.000114	0.000761	CcSEcCtD
Methadone—Hypotension—Capecitabine—kidney cancer	0.000111	0.000746	CcSEcCtD
Methadone—Vomiting—Gemcitabine—kidney cancer	0.00011	0.000739	CcSEcCtD
Methadone—Bradycardia—Doxorubicin—kidney cancer	0.00011	0.000737	CcSEcCtD
Methadone—Rash—Gemcitabine—kidney cancer	0.000109	0.000732	CcSEcCtD
Methadone—Dermatitis—Gemcitabine—kidney cancer	0.000109	0.000732	CcSEcCtD
Methadone—Headache—Gemcitabine—kidney cancer	0.000109	0.000728	CcSEcCtD
Methadone—Nausea—Vincristine—kidney cancer	0.000109	0.000727	CcSEcCtD
Methadone—Insomnia—Capecitabine—kidney cancer	0.000108	0.000722	CcSEcCtD
Methadone—Hypersensitivity—Paclitaxel—kidney cancer	0.000107	0.000716	CcSEcCtD
Methadone—Visual impairment—Doxorubicin—kidney cancer	0.000104	0.000698	CcSEcCtD
Methadone—Asthenia—Paclitaxel—kidney cancer	0.000104	0.000698	CcSEcCtD
Methadone—Decreased appetite—Capecitabine—kidney cancer	0.000104	0.000694	CcSEcCtD
Methadone—Tamoxifen—CYP1A1—kidney cancer	0.000103	0.0411	CrCbGaD
Methadone—Nausea—Gemcitabine—kidney cancer	0.000103	0.00069	CcSEcCtD
Methadone—Pruritus—Paclitaxel—kidney cancer	0.000103	0.000688	CcSEcCtD
Methadone—Constipation—Capecitabine—kidney cancer	0.000102	0.000682	CcSEcCtD
Methadone—Pain—Capecitabine—kidney cancer	0.000102	0.000682	CcSEcCtD
Methadone—Flushing—Doxorubicin—kidney cancer	0.0001	0.000672	CcSEcCtD
Methadone—Diarrhoea—Paclitaxel—kidney cancer	9.94e-05	0.000665	CcSEcCtD
Methadone—Feeling abnormal—Capecitabine—kidney cancer	9.82e-05	0.000658	CcSEcCtD
Methadone—Gastrointestinal pain—Capecitabine—kidney cancer	9.75e-05	0.000653	CcSEcCtD
Methadone—Chills—Doxorubicin—kidney cancer	9.7e-05	0.00065	CcSEcCtD
Methadone—Arrhythmia—Doxorubicin—kidney cancer	9.66e-05	0.000647	CcSEcCtD
Methadone—Dizziness—Paclitaxel—kidney cancer	9.6e-05	0.000643	CcSEcCtD
Methadone—Urticaria—Capecitabine—kidney cancer	9.47e-05	0.000634	CcSEcCtD
Methadone—Abdominal pain—Capecitabine—kidney cancer	9.42e-05	0.000631	CcSEcCtD
Methadone—Body temperature increased—Capecitabine—kidney cancer	9.42e-05	0.000631	CcSEcCtD
Methadone—Erythema—Doxorubicin—kidney cancer	9.41e-05	0.00063	CcSEcCtD
Methadone—Clotrimazole—ABCB1—kidney cancer	9.26e-05	0.0369	CrCbGaD
Methadone—Vomiting—Paclitaxel—kidney cancer	9.23e-05	0.000618	CcSEcCtD
Methadone—Rash—Paclitaxel—kidney cancer	9.16e-05	0.000613	CcSEcCtD
Methadone—Dermatitis—Paclitaxel—kidney cancer	9.15e-05	0.000613	CcSEcCtD
Methadone—Headache—Paclitaxel—kidney cancer	9.1e-05	0.000609	CcSEcCtD
Methadone—Muscle spasms—Doxorubicin—kidney cancer	9.05e-05	0.000606	CcSEcCtD
Methadone—Hypersensitivity—Capecitabine—kidney cancer	8.78e-05	0.000588	CcSEcCtD
Methadone—Agitation—Doxorubicin—kidney cancer	8.65e-05	0.000579	CcSEcCtD
Methadone—Nausea—Paclitaxel—kidney cancer	8.63e-05	0.000578	CcSEcCtD
Methadone—Asthenia—Capecitabine—kidney cancer	8.55e-05	0.000573	CcSEcCtD
Methadone—Vertigo—Doxorubicin—kidney cancer	8.46e-05	0.000566	CcSEcCtD
Methadone—Syncope—Doxorubicin—kidney cancer	8.44e-05	0.000565	CcSEcCtD
Methadone—Pruritus—Capecitabine—kidney cancer	8.43e-05	0.000565	CcSEcCtD
Methadone—Palpitations—Doxorubicin—kidney cancer	8.32e-05	0.000557	CcSEcCtD
Methadone—Loss of consciousness—Doxorubicin—kidney cancer	8.27e-05	0.000554	CcSEcCtD
Methadone—Convulsion—Doxorubicin—kidney cancer	8.16e-05	0.000546	CcSEcCtD
Methadone—Diarrhoea—Capecitabine—kidney cancer	8.15e-05	0.000546	CcSEcCtD
Methadone—Anxiety—Doxorubicin—kidney cancer	7.99e-05	0.000535	CcSEcCtD
Methadone—Fentanyl—ABCB1—kidney cancer	7.92e-05	0.0315	CrCbGaD
Methadone—Dizziness—Capecitabine—kidney cancer	7.88e-05	0.000528	CcSEcCtD
Methadone—Dry mouth—Doxorubicin—kidney cancer	7.84e-05	0.000525	CcSEcCtD
Methadone—Confusional state—Doxorubicin—kidney cancer	7.75e-05	0.000519	CcSEcCtD
Methadone—Anaphylactic shock—Doxorubicin—kidney cancer	7.68e-05	0.000514	CcSEcCtD
Methadone—Oedema—Doxorubicin—kidney cancer	7.68e-05	0.000514	CcSEcCtD
Methadone—Loperamide—ABCB1—kidney cancer	7.63e-05	0.0304	CrCbGaD
Methadone—Vomiting—Capecitabine—kidney cancer	7.58e-05	0.000507	CcSEcCtD
Methadone—Shock—Doxorubicin—kidney cancer	7.56e-05	0.000506	CcSEcCtD
Methadone—Thrombocytopenia—Doxorubicin—kidney cancer	7.52e-05	0.000504	CcSEcCtD
Methadone—Rash—Capecitabine—kidney cancer	7.51e-05	0.000503	CcSEcCtD
Methadone—Dermatitis—Capecitabine—kidney cancer	7.51e-05	0.000503	CcSEcCtD
Methadone—Tachycardia—Doxorubicin—kidney cancer	7.5e-05	0.000502	CcSEcCtD
Methadone—Headache—Capecitabine—kidney cancer	7.47e-05	0.0005	CcSEcCtD
Methadone—Hyperhidrosis—Doxorubicin—kidney cancer	7.43e-05	0.000497	CcSEcCtD
Methadone—Anorexia—Doxorubicin—kidney cancer	7.32e-05	0.00049	CcSEcCtD
Methadone—Hypotension—Doxorubicin—kidney cancer	7.18e-05	0.000481	CcSEcCtD
Methadone—Nausea—Capecitabine—kidney cancer	7.08e-05	0.000474	CcSEcCtD
Methadone—Insomnia—Doxorubicin—kidney cancer	6.95e-05	0.000465	CcSEcCtD
Methadone—Somnolence—Doxorubicin—kidney cancer	6.83e-05	0.000457	CcSEcCtD
Methadone—Decreased appetite—Doxorubicin—kidney cancer	6.68e-05	0.000447	CcSEcCtD
Methadone—Constipation—Doxorubicin—kidney cancer	6.57e-05	0.00044	CcSEcCtD
Methadone—Pain—Doxorubicin—kidney cancer	6.57e-05	0.00044	CcSEcCtD
Methadone—Feeling abnormal—Doxorubicin—kidney cancer	6.33e-05	0.000424	CcSEcCtD
Methadone—Gastrointestinal pain—Doxorubicin—kidney cancer	6.28e-05	0.000421	CcSEcCtD
Methadone—Urticaria—Doxorubicin—kidney cancer	6.1e-05	0.000409	CcSEcCtD
Methadone—Abdominal pain—Doxorubicin—kidney cancer	6.07e-05	0.000407	CcSEcCtD
Methadone—Body temperature increased—Doxorubicin—kidney cancer	6.07e-05	0.000407	CcSEcCtD
Methadone—Trimipramine—ABCB1—kidney cancer	5.73e-05	0.0228	CrCbGaD
Methadone—Hypersensitivity—Doxorubicin—kidney cancer	5.66e-05	0.000379	CcSEcCtD
Methadone—Promethazine—ABCB1—kidney cancer	5.51e-05	0.022	CrCbGaD
Methadone—Asthenia—Doxorubicin—kidney cancer	5.51e-05	0.000369	CcSEcCtD
Methadone—Tamoxifen—ABCB1—kidney cancer	5.48e-05	0.0218	CrCbGaD
Methadone—Pruritus—Doxorubicin—kidney cancer	5.44e-05	0.000364	CcSEcCtD
Methadone—Diarrhoea—Doxorubicin—kidney cancer	5.26e-05	0.000352	CcSEcCtD
Methadone—Dizziness—Doxorubicin—kidney cancer	5.08e-05	0.00034	CcSEcCtD
Methadone—Vomiting—Doxorubicin—kidney cancer	4.88e-05	0.000327	CcSEcCtD
Methadone—Rash—Doxorubicin—kidney cancer	4.84e-05	0.000324	CcSEcCtD
Methadone—Dermatitis—Doxorubicin—kidney cancer	4.84e-05	0.000324	CcSEcCtD
Methadone—Headache—Doxorubicin—kidney cancer	4.81e-05	0.000322	CcSEcCtD
Methadone—Nausea—Doxorubicin—kidney cancer	4.56e-05	0.000306	CcSEcCtD
Methadone—CYP3A5—Metabolism—SLC2A1—kidney cancer	7.29e-06	0.000155	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALAD—kidney cancer	7.27e-06	0.000154	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ITPR2—kidney cancer	7.26e-06	0.000154	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—MAPK3—kidney cancer	7.21e-06	0.000153	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—SCARB1—kidney cancer	7.19e-06	0.000153	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—POMC—kidney cancer	7.17e-06	0.000152	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KDR—kidney cancer	7.17e-06	0.000152	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.16e-06	0.000152	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS1—kidney cancer	7.12e-06	0.000151	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.1e-06	0.000151	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—BRAF—kidney cancer	7.08e-06	0.00015	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PSMD7—kidney cancer	6.98e-06	0.000148	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.94e-06	0.000147	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.93e-06	0.000147	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—MAPK1—kidney cancer	6.86e-06	0.000146	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.85e-06	0.000145	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ITPR2—kidney cancer	6.84e-06	0.000145	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTT1—kidney cancer	6.78e-06	0.000144	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ACHE—kidney cancer	6.78e-06	0.000144	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ITPR2—kidney cancer	6.78e-06	0.000144	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.65e-06	0.000141	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PGK1—kidney cancer	6.65e-06	0.000141	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL2—kidney cancer	6.65e-06	0.000141	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ACHE—kidney cancer	6.62e-06	0.00014	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTT1—kidney cancer	6.62e-06	0.00014	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—BCHE—kidney cancer	6.62e-06	0.00014	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—APC—kidney cancer	6.6e-06	0.00014	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KIT—kidney cancer	6.6e-06	0.00014	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—PIK3CA—kidney cancer	6.55e-06	0.000139	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTGS2—kidney cancer	6.55e-06	0.000139	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—SLC5A5—kidney cancer	6.54e-06	0.000139	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—LDHB—kidney cancer	6.52e-06	0.000138	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—KRAS—kidney cancer	6.48e-06	0.000138	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—SCARB1—kidney cancer	6.42e-06	0.000136	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS1—kidney cancer	6.35e-06	0.000135	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HIF1A—kidney cancer	6.33e-06	0.000134	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—MAPK3—kidney cancer	6.32e-06	0.000134	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TSC2—kidney cancer	6.32e-06	0.000134	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—SLC2A1—kidney cancer	6.31e-06	0.000134	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—POMC—kidney cancer	6.29e-06	0.000134	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—POMC—kidney cancer	6.28e-06	0.000133	CbGpPWpGaD
Methadone—ABCB1—Metabolism—SCARB1—kidney cancer	6.26e-06	0.000133	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.25e-06	0.000133	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTT1—kidney cancer	6.24e-06	0.000132	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ACHE—kidney cancer	6.24e-06	0.000132	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CRABP1—kidney cancer	6.23e-06	0.000132	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PSMD7—kidney cancer	6.23e-06	0.000132	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GSTP1—kidney cancer	6.22e-06	0.000132	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—BRAF—kidney cancer	6.2e-06	0.000132	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS1—kidney cancer	6.2e-06	0.000132	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ACHE—kidney cancer	6.18e-06	0.000131	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTT1—kidney cancer	6.18e-06	0.000131	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.12e-06	0.00013	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PSMD7—kidney cancer	6.08e-06	0.000129	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GSTP1—kidney cancer	6.08e-06	0.000129	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KDR—kidney cancer	6.06e-06	0.000129	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—MAPK1—kidney cancer	6.01e-06	0.000128	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—PIK3CA—kidney cancer	5.95e-06	0.000126	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—RAF1—kidney cancer	5.91e-06	0.000125	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—BCHE—kidney cancer	5.91e-06	0.000125	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—SCARB1—kidney cancer	5.9e-06	0.000125	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ABCB1—kidney cancer	5.89e-06	0.000125	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—RELA—kidney cancer	5.88e-06	0.000125	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—SCARB1—kidney cancer	5.85e-06	0.000124	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—ERBB2—kidney cancer	5.84e-06	0.000124	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS1—kidney cancer	5.84e-06	0.000124	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—SLC5A5—kidney cancer	5.83e-06	0.000124	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ITPR2—kidney cancer	5.79e-06	0.000123	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS1—kidney cancer	5.79e-06	0.000123	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MTOR—kidney cancer	5.77e-06	0.000122	CbGpPWpGaD
Methadone—ABCB1—Metabolism—BCHE—kidney cancer	5.76e-06	0.000122	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ABCB1—kidney cancer	5.75e-06	0.000122	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—PIK3CA—kidney cancer	5.75e-06	0.000122	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PSMD7—kidney cancer	5.73e-06	0.000122	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTEN—kidney cancer	5.71e-06	0.000121	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GSTM1—kidney cancer	5.71e-06	0.000121	CbGpPWpGaD
Methadone—ABCB1—Metabolism—SLC5A5—kidney cancer	5.69e-06	0.000121	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—KRAS—kidney cancer	5.68e-06	0.000121	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PSMD7—kidney cancer	5.68e-06	0.000121	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CA9—kidney cancer	5.66e-06	0.00012	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—SLC2A1—kidney cancer	5.63e-06	0.00012	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GSTM1—kidney cancer	5.59e-06	0.000119	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—APC—kidney cancer	5.58e-06	0.000118	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KIT—kidney cancer	5.58e-06	0.000118	CbGpPWpGaD
Methadone—ABCB1—Metabolism—SLC2A1—kidney cancer	5.5e-06	0.000117	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.47e-06	0.000116	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—POMC—kidney cancer	5.46e-06	0.000116	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—BCHE—kidney cancer	5.43e-06	0.000115	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP1A1—kidney cancer	5.42e-06	0.000115	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CDKN1B—kidney cancer	5.41e-06	0.000115	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—BCHE—kidney cancer	5.39e-06	0.000114	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—SLC5A5—kidney cancer	5.37e-06	0.000114	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—MAPK3—kidney cancer	5.34e-06	0.000113	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.34e-06	0.000113	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.34e-06	0.000113	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—SLC5A5—kidney cancer	5.32e-06	0.000113	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—POMC—kidney cancer	5.31e-06	0.000113	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL2—kidney cancer	5.3e-06	0.000112	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP1A1—kidney cancer	5.3e-06	0.000112	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTT1—kidney cancer	5.28e-06	0.000112	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ACHE—kidney cancer	5.28e-06	0.000112	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTP1—kidney cancer	5.26e-06	0.000112	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.24e-06	0.000111	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—BRAF—kidney cancer	5.24e-06	0.000111	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—PIK3CA—kidney cancer	5.22e-06	0.000111	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—SLC2A1—kidney cancer	5.18e-06	0.00011	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—RAF1—kidney cancer	5.18e-06	0.00011	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCND1—kidney cancer	5.16e-06	0.00011	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—RELA—kidney cancer	5.16e-06	0.000109	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—JUN—kidney cancer	5.15e-06	0.000109	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.14e-06	0.000109	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—ERBB2—kidney cancer	5.13e-06	0.000109	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CTNNB1—kidney cancer	5.11e-06	0.000109	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—MAPK1—kidney cancer	5.08e-06	0.000108	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MTOR—kidney cancer	5.06e-06	0.000107	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTGS2—kidney cancer	5.02e-06	0.000106	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SCARB1—kidney cancer	5e-06	0.000106	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.98e-06	0.000106	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PTEN—kidney cancer	4.98e-06	0.000106	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ABCB1—kidney cancer	4.98e-06	0.000106	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS1—kidney cancer	4.95e-06	0.000105	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—PIK3CA—kidney cancer	4.86e-06	0.000103	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PSMD7—kidney cancer	4.85e-06	0.000103	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTM1—kidney cancer	4.84e-06	0.000103	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CRABP1—kidney cancer	4.81e-06	0.000102	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—KRAS—kidney cancer	4.8e-06	0.000102	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.77e-06	0.000101	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CDKN1B—kidney cancer	4.75e-06	0.000101	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTP1—kidney cancer	4.7e-06	9.98e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL2—kidney cancer	4.64e-06	9.86e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—BCHE—kidney cancer	4.6e-06	9.77e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTP1—kidney cancer	4.59e-06	9.74e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP1A1—kidney cancer	4.59e-06	9.74e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SLC5A5—kidney cancer	4.55e-06	9.65e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCND1—kidney cancer	4.53e-06	9.61e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—JUN—kidney cancer	4.52e-06	9.59e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—kidney cancer	4.5e-06	9.56e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CTNNB1—kidney cancer	4.48e-06	9.52e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ITPR2—kidney cancer	4.47e-06	9.49e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ABCB1—kidney cancer	4.45e-06	9.44e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PIK3CA—kidney cancer	4.41e-06	9.36e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SLC2A1—kidney cancer	4.39e-06	9.32e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—RAF1—kidney cancer	4.38e-06	9.29e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTEN—kidney cancer	4.37e-06	9.29e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PTEN—kidney cancer	4.37e-06	9.28e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—RELA—kidney cancer	4.36e-06	9.25e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—kidney cancer	4.36e-06	9.25e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.35e-06	9.23e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ERBB2—kidney cancer	4.33e-06	9.2e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTP1—kidney cancer	4.32e-06	9.18e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTM1—kidney cancer	4.32e-06	9.17e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTP1—kidney cancer	4.28e-06	9.1e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MTOR—kidney cancer	4.27e-06	9.07e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.26e-06	9.04e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK3—kidney cancer	4.26e-06	9.04e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTM1—kidney cancer	4.21e-06	8.95e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MYC—kidney cancer	4.14e-06	8.79e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP1A1—kidney cancer	4.09e-06	8.69e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ABCB1—kidney cancer	4.09e-06	8.69e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ACHE—kidney cancer	4.08e-06	8.65e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTT1—kidney cancer	4.08e-06	8.65e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ABCB1—kidney cancer	4.06e-06	8.61e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK1—kidney cancer	4.05e-06	8.6e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—POMC—kidney cancer	4.04e-06	8.57e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PIK3CA—kidney cancer	4.03e-06	8.56e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDKN1B—kidney cancer	4.01e-06	8.52e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP1A1—kidney cancer	4e-06	8.48e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTM1—kidney cancer	3.97e-06	8.43e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—POMC—kidney cancer	3.95e-06	8.38e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—kidney cancer	3.95e-06	8.38e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTM1—kidney cancer	3.94e-06	8.36e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL2—kidney cancer	3.93e-06	8.33e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SCARB1—kidney cancer	3.86e-06	8.19e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KRAS—kidney cancer	3.83e-06	8.12e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCND1—kidney cancer	3.83e-06	8.12e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS1—kidney cancer	3.82e-06	8.11e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—JUN—kidney cancer	3.82e-06	8.11e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTEN—kidney cancer	3.8e-06	8.07e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CTNNB1—kidney cancer	3.79e-06	8.05e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.77e-06	8e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.77e-06	7.99e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PSMD7—kidney cancer	3.75e-06	7.95e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK3—kidney cancer	3.73e-06	7.93e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.73e-06	7.92e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.71e-06	7.89e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTEN—kidney cancer	3.69e-06	7.84e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTP1—kidney cancer	3.66e-06	7.77e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MYC—kidney cancer	3.63e-06	7.71e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK1—kidney cancer	3.55e-06	7.54e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—BCHE—kidney cancer	3.55e-06	7.54e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PIK3CA—kidney cancer	3.52e-06	7.46e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.51e-06	7.45e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ABCB1—kidney cancer	3.47e-06	7.36e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—POMC—kidney cancer	3.42e-06	7.26e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—kidney cancer	3.4e-06	7.22e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.39e-06	7.19e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTM1—kidney cancer	3.36e-06	7.14e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.36e-06	7.14e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KRAS—kidney cancer	3.36e-06	7.12e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—kidney cancer	3.34e-06	7.08e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—kidney cancer	3.22e-06	6.84e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.19e-06	6.77e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK3—kidney cancer	3.16e-06	6.7e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—kidney cancer	3.15e-06	6.69e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PIK3CA—kidney cancer	3.09e-06	6.55e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PIK3CA—kidney cancer	3.08e-06	6.55e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MYC—kidney cancer	3.07e-06	6.52e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.07e-06	6.51e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—POMC—kidney cancer	3.05e-06	6.48e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK1—kidney cancer	3e-06	6.37e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—kidney cancer	2.98e-06	6.33e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—POMC—kidney cancer	2.98e-06	6.32e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KRAS—kidney cancer	2.84e-06	6.02e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTP1—kidney cancer	2.83e-06	6e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTEN—kidney cancer	2.81e-06	5.96e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—POMC—kidney cancer	2.81e-06	5.96e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—POMC—kidney cancer	2.78e-06	5.91e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTEN—kidney cancer	2.75e-06	5.83e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—kidney cancer	2.73e-06	5.79e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.68e-06	5.69e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ABCB1—kidney cancer	2.67e-06	5.68e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.62e-06	5.56e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CA—kidney cancer	2.61e-06	5.53e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTM1—kidney cancer	2.6e-06	5.51e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—kidney cancer	2.52e-06	5.35e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.46e-06	5.23e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—kidney cancer	2.43e-06	5.17e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTEN—kidney cancer	2.38e-06	5.05e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—POMC—kidney cancer	2.38e-06	5.05e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—kidney cancer	2.38e-06	5.04e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—kidney cancer	2.24e-06	4.75e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—kidney cancer	2.22e-06	4.71e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTEN—kidney cancer	2.12e-06	4.51e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTEN—kidney cancer	2.07e-06	4.4e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.98e-06	4.21e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTEN—kidney cancer	1.95e-06	4.15e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.94e-06	4.11e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTEN—kidney cancer	1.94e-06	4.11e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—kidney cancer	1.9e-06	4.03e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—POMC—kidney cancer	1.84e-06	3.9e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.68e-06	3.56e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTEN—kidney cancer	1.65e-06	3.51e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.5e-06	3.18e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.46e-06	3.11e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CA—kidney cancer	1.46e-06	3.1e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.38e-06	2.92e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.37e-06	2.9e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTEN—kidney cancer	1.28e-06	2.71e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.17e-06	2.48e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.01e-07	1.91e-05	CbGpPWpGaD
